FR2699820B3 - Homeopathic preventive treatment of dysmytosis (cancer, leukemia) and genetic malformations or mutations. - Google Patents

Homeopathic preventive treatment of dysmytosis (cancer, leukemia) and genetic malformations or mutations.

Info

Publication number
FR2699820B3
FR2699820B3 FR9216025A FR9216025A FR2699820B3 FR 2699820 B3 FR2699820 B3 FR 2699820B3 FR 9216025 A FR9216025 A FR 9216025A FR 9216025 A FR9216025 A FR 9216025A FR 2699820 B3 FR2699820 B3 FR 2699820B3
Authority
FR
France
Prior art keywords
dysmytosis
homeopathic
leukemia
mutations
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9216025A
Other languages
French (fr)
Other versions
FR2699820A1 (en
Inventor
Eric Pichot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR9216025A priority Critical patent/FR2699820B3/en
Publication of FR2699820A1 publication Critical patent/FR2699820A1/en
Application granted granted Critical
Publication of FR2699820B3 publication Critical patent/FR2699820B3/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/121—Solutions, i.e. homogeneous liquid formulation
FR9216025A 1992-12-24 1992-12-24 Homeopathic preventive treatment of dysmytosis (cancer, leukemia) and genetic malformations or mutations. Expired - Fee Related FR2699820B3 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9216025A FR2699820B3 (en) 1992-12-24 1992-12-24 Homeopathic preventive treatment of dysmytosis (cancer, leukemia) and genetic malformations or mutations.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9216025A FR2699820B3 (en) 1992-12-24 1992-12-24 Homeopathic preventive treatment of dysmytosis (cancer, leukemia) and genetic malformations or mutations.

Publications (2)

Publication Number Publication Date
FR2699820A1 FR2699820A1 (en) 1994-07-01
FR2699820B3 true FR2699820B3 (en) 1995-03-10

Family

ID=9437374

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9216025A Expired - Fee Related FR2699820B3 (en) 1992-12-24 1992-12-24 Homeopathic preventive treatment of dysmytosis (cancer, leukemia) and genetic malformations or mutations.

Country Status (1)

Country Link
FR (1) FR2699820B3 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2713487B1 (en) * 1993-12-09 1996-02-02 Labo Life Homeopathic type solutions containing a nucleic acid which can be used in particular for the prevention or treatment of infectious diseases or of diseases involving the dysfunction of a gene.
CN1282218A (en) 1997-10-15 2001-01-31 波拉克斯生物药品 Compositions and method for treatment of primary and metastatic neoplastic diseases using arsenic compounds
ZA991792B (en) * 1998-04-29 1999-09-16 Trevor Wasserman Mouthwash composition.
AU6449500A (en) * 1999-06-18 2001-01-09 Pascal Berdal Method for obtaining health-promoting products and resulting products
FR2800575B1 (en) * 1999-11-08 2003-01-24 Pascal Berdal PROCESS FOR PREPARING FOOD AND FOOD SUPPLEMENTS HAVING HEALTH EFFECTS
GB0119052D0 (en) * 2001-08-03 2001-09-26 Mars Uk Ltd Foodstuff

Also Published As

Publication number Publication date
FR2699820A1 (en) 1994-07-01

Similar Documents

Publication Publication Date Title
FR2699065B1 (en) Self-compressing screw for the treatment of epiphyseal and / or osteochondral fractures.
FR2739255B1 (en) PEST CONTROL COMPOSITION FOR THE TREATMENT AND PROTECTION OF PETS
BG104599A (en) Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
ZA943744B (en) Therapeutic substituted guanidines
HU9501146D0 (en) 2-amino-4-phenyl-4-oxo-butyric acid derivatives with kynureninase and/or kynurenine-3-hydroxylase inhibiting activity
ATE367808T1 (en) N-CHLORPHENYL CARBAMATES CONTAINING MEDICINAL PRODUCT AND N-CHLORPHENYLTHIOCARBAMATES FOR INHIBITING THE GROWTH OF VIRUSES
MXPA94009086A (en) Therapeutic substituted guanidines.
FR2699820B3 (en) Homeopathic preventive treatment of dysmytosis (cancer, leukemia) and genetic malformations or mutations.
NO961226L (en) Compounds for the prevention and treatment of viral-induced tumors
HUP0100611A2 (en) Triazine compounds for treatment of cns disorders
NO981662D0 (en) Diagnosis of cancer predispositions and treatment of this
BR9305687A (en) Processes and preparations for treating cesium ions and / or magnesium ions
HUP9802536A3 (en) Pharmaceutical compositions containing 1,2,4-benzotriazine 1,4-dioxide and use thereof for the preparation of pharmaceutical compositions treating cancer
ZA962141B (en) Treatment and prevention of prostatic cancer.
GR3033061T3 (en) Use of benzonaphthalene derivatives to make medicaments for treating diseases of the central nervous system
EP0679083A4 (en) Prevention and treatment of sepsis.
ZA93211B (en) Enzyme castration of animals and tumor treatment.
TR199902564T2 (en) Use of cartilage oligomer matrix protein in the treatment of rheumatoid arthritis.
EP0653208A3 (en) Pharmaceutical agents for treatment or prevention of sunburn.
ITRM920305A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF THE SHOCK, PARTICULARLY OF THE CARDIOGEN SHOCK AND SEPTIC SHOCK.
EP0655919A4 (en) Treatment of human viral infections.
FR2690152B1 (en) PROCESS FOR THE PREPARATION AND TREATMENT OF PROPELLANTS.
GB9317943D0 (en) Treatment of laminitis
DE69737570D1 (en) Agents for presymptomatic detection, prevention and treatment of breast cancer in humans
AU5556094A (en) Nucleotide sequence for treating cancer and infection

Legal Events

Date Code Title Description
ST Notification of lapse